NDC 0006-4943

PNEUMOVAX 23

Pneumococcal Vaccine Polyvalent

PNEUMOVAX 23 is a Intramuscular; Subcutaneous Injection, Solution in the Vaccine category. It is labeled and distributed by Merck Sharp & Dohme Corp.. The primary component is Streptococcus Pneumoniae Type 1 Capsular Polysaccharide Antigen; Streptococcus Pneumoniae Type 2 Capsular Polysaccharide Antigen; Streptococcus Pneumoniae Type 3 Capsular Polysaccharide Antigen; Streptococcus Pneumoniae Type 4 Capsular Polysaccharide Antigen; Streptococcus Pneumoniae Type 5 Capsular Polysaccharide Antigen; Streptococcus Pneumoniae Type 6b Capsular Polysaccharide Antigen; Streptococcus Pneumoniae Type 7f Capsular Polysaccharide Antigen; Streptococcus Pneumoniae Type 8 Capsular Polysaccharide Antigen; Streptococcus Pneumoniae Type 9n Capsular Polysaccharide Antigen; Streptococcus Pneumoniae Type 9v Capsular Polysaccharide Antigen; Streptococcus Pneumoniae Type 10a Capsular Polysaccharide Antigen; Streptococcus Pneumoniae Type 11a Capsular Polysaccharide Antigen; Streptococcus Pneumoniae Type 12f Capsular Polysaccharide Antigen; Streptococcus Pneumoniae Type 14 Capsular Polysaccharide Antigen; Streptococcus Pneumoniae Type 15b Capsular Polysaccharide Antigen; Streptococcus Pneumoniae Type 17f Capsular Polysaccharide Antigen; Streptococcus Pneumoniae Type 18c Capsular Polysaccharide Antigen; Streptococcus Pneumoniae Type 19f Capsular Polysaccharide Antigen; Streptococcus Pneumoniae Type 19a Capsular Polysaccharide Antigen; Streptococcus Pneumoniae Type 20 Capsular Polysaccharide Antigen; Streptococcus Pneumoniae Type 22f Capsular Polysaccharide Antigen; Streptococcus Pneumoniae Type 23f Capsular Polysaccharide Antigen; Streptococcus Pneumoniae Type 33f Capsular Polysaccharide Antigen.

Product ID0006-4943_06a8835f-ff57-43a4-b253-4241226489a5
NDC0006-4943
Product TypeVaccine
Proprietary NamePNEUMOVAX 23
Generic NamePneumococcal Vaccine Polyvalent
Dosage FormInjection, Solution
Route of AdministrationINTRAMUSCULAR; SUBCUTANEOUS
Marketing Start Date1983-07-07
Marketing CategoryBLA / BLA
Application NumberBLA101094
Labeler NameMerck Sharp & Dohme Corp.
Substance NameSTREPTOCOCCUS PNEUMONIAE TYPE 1 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 2 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 3 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 4 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 5 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 6B CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 7F CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 8 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 9N CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 9V CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 10A CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 11A CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 12F CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 14 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 15B CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 17F CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 18C CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 19F CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 19A CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 20 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 22F CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 23F CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 33F CAPSULAR POLYSACCHARIDE ANTIGEN
Active Ingredient Strength25 ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL
Pharm ClassesInactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [CS],Vaccines, Inactivated [CS],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [CS],Vaccines, Inactivated [CS],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [CS],Vaccines, Inactivated [CS],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [CS],Vaccines, Inactivated [CS],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [CS],Vaccines, Inactivated [CS],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [CS],Vaccines, Inactivated [CS],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [CS],Vaccines, Inactivated [CS],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [CS],Vaccines, Inactivated [CS],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [CS],Vaccines, Inactivated [CS],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [CS],Vaccines, Inactivated [CS],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [CS],Vaccines, Inactivated [CS],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [CS],Vaccines, Inactivated [CS],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [CS],Vaccines, Inactivated [CS],Vaccines, Inactivated [CS],Pneumococcal Vaccines [CS],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [CS],Vaccines, Inactivated [CS],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [CS],Vaccines, Inactivated [CS],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [CS],Vaccines, Inactivated [CS],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [CS],Vaccines, Inactivated [CS],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [CS],Vaccines, Inactivated [CS],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [CS],Vaccines, Inactivated [CS],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [CS],Vaccines, Inactivated [CS],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [CS],Vaccines, Inactivated [CS],Inactivated Pneumococcal Vaccine [EPC],Actively Acquired Immunity [PE],Pneumococcal Vaccines [CS],Vaccines, Inactivated [CS]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 0006-4943-00

10 VIAL, SINGLE-DOSE in 1 CARTON (0006-4943-00) > .5 mL in 1 VIAL, SINGLE-DOSE (0006-4943-01)
Marketing Start Date1983-07-07
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0006-4943-01 [00006494301]

PNEUMOVAX 23 INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA101094
Product TypeVACCINE
Billing UnitML
Marketing Start Date2013-05-10

NDC 0006-4943-00 [00006494300]

PNEUMOVAX 23 INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA101094
Product TypeVACCINE
Billing UnitML
Marketing Start Date1983-07-07

Drug Details

Active Ingredients

IngredientStrength
STREPTOCOCCUS PNEUMONIAE TYPE 1 CAPSULAR POLYSACCHARIDE ANTIGEN25 ug/.5mL

Pharmacological Class

  • Inactivated Pneumococcal Vaccine [EPC]
  • Actively Acquired Immunity [PE]
  • Pneumococcal Vaccines [CS]
  • Vaccines
  • Inactivated [CS]
  • Inactivated Pneumococcal Vaccine [EPC]
  • Actively Acquired Immunity [PE]
  • Pneumococcal Vaccines [CS]
  • Vaccines
  • Inactivated [CS]
  • Inactivated Pneumococcal Vaccine [EPC]
  • Actively Acquired Immunity [PE]
  • Pneumococcal Vaccines [CS]
  • Vaccines
  • Inactivated [CS]
  • Inactivated Pneumococcal Vaccine [EPC]
  • Actively Acquired Immunity [PE]
  • Pneumococcal Vaccines [CS]
  • Vaccines
  • Inactivated [CS]
  • Inactivated Pneumococcal Vaccine [EPC]
  • Actively Acquired Immunity [PE]
  • Pneumococcal Vaccines [CS]
  • Vaccines
  • Inactivated [CS]
  • Inactivated Pneumococcal Vaccine [EPC]
  • Actively Acquired Immunity [PE]
  • Pneumococcal Vaccines [CS]
  • Vaccines
  • Inactivated [CS]
  • Inactivated Pneumococcal Vaccine [EPC]
  • Actively Acquired Immunity [PE]
  • Pneumococcal Vaccines [CS]
  • Vaccines
  • Inactivated [CS]
  • Inactivated Pneumococcal Vaccine [EPC]
  • Actively Acquired Immunity [PE]
  • Pneumococcal Vaccines [CS]
  • Vaccines
  • Inactivated [CS]
  • Inactivated Pneumococcal Vaccine [EPC]
  • Actively Acquired Immunity [PE]
  • Pneumococcal Vaccines [CS]
  • Vaccines
  • Inactivated [CS]
  • Inactivated Pneumococcal Vaccine [EPC]
  • Actively Acquired Immunity [PE]
  • Pneumococcal Vaccines [CS]
  • Vaccines
  • Inactivated [CS]
  • Inactivated Pneumococcal Vaccine [EPC]
  • Actively Acquired Immunity [PE]
  • Pneumococcal Vaccines [CS]
  • Vaccines
  • Inactivated [CS]
  • Inactivated Pneumococcal Vaccine [EPC]
  • Actively Acquired Immunity [PE]
  • Pneumococcal Vaccines [CS]
  • Vaccines
  • Inactivated [CS]
  • Inactivated Pneumococcal Vaccine [EPC]
  • Actively Acquired Immunity [PE]
  • Pneumococcal Vaccines [CS]
  • Vaccines
  • Inactivated [CS]
  • Inactivated Pneumococcal Vaccine [EPC]
  • Actively Acquired Immunity [PE]
  • Pneumococcal Vaccines [CS]
  • Vaccines
  • Inactivated [CS]
  • Inactivated Pneumococcal Vaccine [EPC]
  • Actively Acquired Immunity [PE]
  • Pneumococcal Vaccines [CS]
  • Vaccines
  • Inactivated [CS]
  • Inactivated Pneumococcal Vaccine [EPC]
  • Actively Acquired Immunity [PE]
  • Pneumococcal Vaccines [CS]
  • Vaccines
  • Inactivated [CS]
  • Inactivated Pneumococcal Vaccine [EPC]
  • Actively Acquired Immunity [PE]
  • Pneumococcal Vaccines [CS]
  • Vaccines
  • Inactivated [CS]
  • Inactivated Pneumococcal Vaccine [EPC]
  • Actively Acquired Immunity [PE]
  • Pneumococcal Vaccines [CS]
  • Vaccines
  • Inactivated [CS]
  • Inactivated Pneumococcal Vaccine [EPC]
  • Actively Acquired Immunity [PE]
  • Pneumococcal Vaccines [CS]
  • Vaccines
  • Inactivated [CS]
  • Inactivated Pneumococcal Vaccine [EPC]
  • Actively Acquired Immunity [PE]
  • Pneumococcal Vaccines [CS]
  • Vaccines
  • Inactivated [CS]
  • Inactivated Pneumococcal Vaccine [EPC]
  • Actively Acquired Immunity [PE]
  • Pneumococcal Vaccines [CS]
  • Vaccines
  • Inactivated [CS]
  • Inactivated Pneumococcal Vaccine [EPC]
  • Actively Acquired Immunity [PE]
  • Pneumococcal Vaccines [CS]
  • Vaccines
  • Inactivated [CS]
  • Vaccines
  • Inactivated [CS]
  • Pneumococcal Vaccines [CS]
  • Inactivated Pneumococcal Vaccine [EPC]
  • Actively Acquired Immunity [PE]

NDC Crossover Matching brand name "PNEUMOVAX 23" or generic name "Pneumococcal Vaccine Polyvalent"

NDCBrand NameGeneric Name
0006-4837PNEUMOVAX 23pneumococcal vaccine polyvalent
0006-4943PNEUMOVAX 23pneumococcal vaccine polyvalent
50090-1452PNEUMOVAX 23pneumococcal vaccine polyvalent
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.